Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.91 |
| ▸ | BLM | P54132 | 1/20 | 0.91 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.91 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | INPPL1 | O15357 | 2/20 | 0.35 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.35 |
| ▸ | INPP5B | P32019 | 1/20 | 0.35 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.35 |
| ▸ | ITPR3 | Q14573 | 3/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | ITPR2 | Q14571 | 1/20 | 0.33 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL21647245 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL292348 | 0.95 | FDPS (1.00) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL29634664 | 0.95 | — | — | |
| Pyrophosphoric Acid SCHEMBL3654 | 0.95 | — | — | |
| Pyrophosphoric Acid SCHEMBL8851914 | 0.95 | FDPS (1.00) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL23537580 | 0.91 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL21145230 | 0.91 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL396637 | 0.91 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL21433694 | 0.91 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL11587546 | 0.91 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3565561-B1 | PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS FOR TREATMENT OF BONE BLOOD CANCERS | PROMONTORY THERAPEUTICS INC (US) | 2026-05-06 | — | — | EP | claimed |
| US-11439619-B2 | Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof | PHOSPLATIN THERAPEUTICS INC. (US) | 2022-09-13 | — | — | US | claimed |
| US-20210121434-A1 | Phosphaplatin Compounds as Immuno-Modulatory Agents and Therapeutic Uses Thereof | PHOSPLATIN THERAPEUTICS LLC (US) | 2021-04-29 | — | — | US | claimed |
| EP-3679046-A1 | PHOSPHAPLATIN COMPOUNDS AS IMMUNO-MODULATORY AGENTS AND THERAPEUTIC USES THEREOF | Phosplatin Therapeutics LLC (US) | 2020-07-15 | — | — | EP | claimed |
| CN-111328330-A | Phosphaplatins as immunomodulators and their therapeutic use | 弗斯普拉廷治疗有限责任公司 | 2020-06-23 | — | — | CN | claimed |
| US-10668080-B2 | Phosphaplatin compounds as therapeutic agents for treatment of bone or blood cancers | PHOSPLATIN THERAPEUTICS LLC (US) | 2020-06-02 | — | — | US | claimed |
| CN-106967124-B | Synthesis and purification method of phosphorus platinum compound and application thereof | 弗斯普拉廷治疗有限责任公司 | 2020-03-06 | — | — | CN | claimed |
| EP-3565561-A1 | PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS FOR TREATMENT OF BONE BLOOD CANCERS | Phosplatin Therapeutics LLC (US) | 2019-11-13 | — | — | EP | claimed |
| US-20190328748-A1 | PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS FOR TREATMENT OF BONE OR BLOOD CANCERS | PROMONTORY THERAPEUTICS INC. | 2019-10-31 | — | — | US | claimed |
| EP-3202769-B1 | PURIFICATION METHOD FOR PHOSPHAPLATIN COMPOUNDS | PHOSPLATIN THERAPEUTICS LLC (US) | 2019-10-02 | — | — | EP | claimed |
| CN-104540839-B | Synthesis and purification method of phosphorus platinum compound and application thereof | 弗斯普拉廷治疗有限责任公司 | 2017-02-22 | — | — | CN | claimed |
| EP-2855496-B1 | SYNTHETIC AND PURIFICATION METHODS FOR PHOSPHAPLATIN COMPOUNDS AND USES THEREOF | PHOSPLATIN THERAPEUTICS LLC (US) | 2016-12-14 | — | — | EP | claimed |
| CN-104540839-A | Synthesis and purification method of phosphorus platinum compound and application thereof | PHOSPLATIN THERAPEUTICS LLC | 2015-04-22 | — | — | CN | claimed |
| EP-2855496-A1 | SYNTHETIC AND PURIFICATION METHODS FOR PHOSPHAPLATIN COMPOUNDS AND USES THEREOF | Phosplatin Therapeutics LLC (US) | 2015-04-08 | — | — | EP | claimed |
| US-8859796-B1 | Synthetic and purification methods for phosphaplatin compounds and uses thereof | Phosplatin Therapeutics (US) | 2014-10-14 | — | — | US | claimed |
| US-8846964-B2 | Synthetic method for phosphaplatin compounds | Phosplatin Therapeutics (US) | 2014-09-30 | — | — | US | claimed |
| US-20140288321-A1 | Synthetic and Purification Methods for Phosphaplatin Compounds and Uses Thereof | PHOSPLATIN THERAPEUTICS LLC (US) | 2014-09-25 | — | — | US | claimed |
| US-20140024848-A1 | Synthetic Method for Phosphaplatin Compounds | PHOSPLATIN THERAPEUTICS LLC (US) | 2014-01-23 | — | — | US | claimed |
| WO-2013176764-A1 | SYNTHETIC AND PURIFICATION METHODS FOR PHOSPHAPLATIN COMPOUNDS AND USES THEREOF | PHOSPLATIN THERAPEUTICS LLC (US) | 2013-11-28 | — | — | WO | claimed |
| US-4052323-A | HIGH-TEMPERATURE LUBRICANT FOR THE HOT-WORKING OF METALS | LONZA, LTD. (CH) | 1977-10-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288321-A1 | Synthetic and Purification Methods for Phosphaplatin Compounds and Uses Thereof | PHOSPHO1, PPIP5K2, PEBP1 | FDPS 427/4885BLM 2464/4885TDP1 3160/4885 |
| US-20190328748-A1 | PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS FOR TREATMENT OF BONE OR BLOOD CANCERS | PHOSPHO1, PHPT1, PPIP5K2 | FDPS 2400/4885BLM 1979/4885TDP1 2510/4885 |
| US-20140024848-A1 | Synthetic Method for Phosphaplatin Compounds | PPIP5K2, PHOSPHO1, PEBP1 | FDPS 180/4885BLM 2467/4885TDP1 3217/4885 |
| US-11439619-B2 | Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof | PDCD1, PDCD4, PDCD1LG2 | FDPS 1436/4885BLM 2089/4885TDP1 2661/4885 |
| US-20210121434-A1 | Phosphaplatin Compounds as Immuno-Modulatory Agents and Therapeutic Uses Thereof | PDCD1, PDCD4, PDCD1LG2 | FDPS 1436/4885BLM 2089/4885TDP1 2661/4885 |
| US-10668080-B2 | Phosphaplatin compounds as therapeutic agents for treatment of bone or blood cancers | PHOSPHO1, MPL, PPIP5K2 | FDPS 2576/4885BLM 1761/4885TDP1 2575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.